BLRX - BioLineRx Ltd. (BLRX) Q1 2024 Earnings Call Transcript
2024-05-28 17:56:01 ET
BioLineRx Ltd. (BLRX)
Q1 2024 Earnings Call Transcript
May 28, 2024, 08:30 AM ET
Company Participants
John Lacey - Head of IR and Corporate Communications
Phil Serlin - CEO
Holly May - President of BioLineRx USA
Mali Zeevi - CFO
Conference Call Participants
Joe Pantginis - HC Wainwright
John Vandermosten - Zacks
Presentation
Operator
Ladies and gentlemen, thank you for standing by. Welcome to the BioLineRx First Quarter 2024 Financial Results Conference Call. All participants are presently in a listen-only mode. Following management's formal presentation, instructions will be given for the question-and-answer session. I would now like to turn over the call to John Lacey, Head of Investor Relations and Corporate Communications. John, please go ahead.
John Lacey
Thank you, operator. Welcome, everyone. Thank you for joining us on our first quarter 2024 results conference call. Earlier today, we issued a press release, a copy of which is available in the Investor Relations section of our website. It was also filed as a 6-K. I'd like to remind you that certain statements we make during the call will be forward-looking. Because such statements deal with future events and are subject to many risks and uncertainties, actual results may differ materially from those in the forward-looking statements. For a full discussion of these risks and uncertainties, please review our annual report on Form 20-F and our quarterly reports on Form 6-K that are filed with the US Securities and Exchange Commission. At this time, it is now my pleasure to turn the call over to Mr. Phil Serlin, Chief Executive Officer of BioLineRx....
BioLineRx Ltd. (BLRX) Q1 2024 Earnings Call Transcript